What a week, month I mean. The first three quarters of 2022 have been disasterous for investors of all types. Recall that year-to-date through Q3 had been the worst start for a 60/40 portfolio since 1974, which was also an inflation and Fed hiking regime. However, as detailed in the Ned Davis Research chart below, following the other 2 drops below…
Worse Economy, Better Markets
A financial market resource for the every-day investor and trader.
-
12-Month Recovery Roadmap
Seth Golden, , Research Reports, 0
The S&P 500 finished the month of June down -15%+ over the last 3 months and -20%+ over the...
-
J.P. Morgan: A Powerful Consumer Setup into Global Reopening
Seth Golden, , Research Reports, 0
A strong US consumer setup at a time of economic reopening to unleash pent-up demand and drive growth. Our...
-
Weekly State of the Market: Brewing Under The Surface
Seth Golden, , Research Reports, 0
Patient, tactical, resourced, and disciplined investors are always rewarded! Manage those characteristics and you will “massage” your returns higher!...
-
The J.P. Morgan View: CPI Risks Rising
Seth Golden, , Research Reports, 0
Cross-Asset Strategy: The growth-policy tradeoff appears set to improve in 2H, and earnings revisions turned broadly positive in key...
-
Morgan Stanley: FOMC Preview: December Meeting
Seth Golden, , Research Reports, 0
By Ellen Zetner chief U.S. ecoomist: We expect the Fed to hold the policy rate at 5.375% and to...
-
Be Careful With A Long VIX Strategy
Seth Golden, , Research Reports, 0
Three trading weeks have been logged in the New Year and with that… still no signs of increasing volatility...
-
3Fourteen Research: The Path to a Pivot
Seth Golden, , Research Reports, 0
Approaching the end of the year, it is natural to wonder: What lies ahead? Where does this road lead?...
-
Still Growing, In Spite of Geopolitical Headwinds
Seth Golden, , Research Reports, 0
Well, that was much to do about nothing given the anticipation that came ahead of the trading week. When...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00